Exchange: NASDAQ·Updated 09:29 AM EST

KEQU News

News
all
press releases
Kewanee Scientific To Buy Nycom
(RTTNews) - On Monday, Kewaunee Scientific Corporation (NASDAQ: KEQU) signed a definitive agreement to acquire Nycom, Inc., the largest laboratory dealer in the U.S...
Nasdaq News: Markets
Kewanee Scientific To Buy Nycom
(RTTNews) - On Monday, Kewaunee Scientific Corporation (NASDAQ: KEQU) signed a definitive agreement to acquire Nycom, Inc., the largest laboratory dealer in the U.S...
Nasdaq News: Markets
More News
Kewaunee Scientific Announces Agreement to Acquire Nycom, Inc.
Kewaunee Scientific Announces Agreement to Acquire Nycom, Inc. Kewaunee Scientific Announces Agreement to Acquire Nycom, Inc.PR NewswireSTATESVILLE, N.C., Nov. 2, 2026 STATESVILLE, N.C., Nov. 2, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that it has entered...
PR Newswire
The Zacks Analyst Blog Highlights Salesforce, S&P Global, Intuit, Kewaunee Scientific and Key Tronic
CRM, SPGI and INTU face execution challenges, while AI adoption, recurring revenues and product expansion shape their outlooks alongside micro-cap stocks KEQU and KTCC.
Zacks
Top Analyst Reports for Salesforce, S&P & Intuit
Salesforce, S&P Global and Intuit navigate AI-driven growth opportunities, recurring revenue gains and strategic shifts while facing competition, cost pressures and execution risks.
Zacks
Kewaunee Q1 Earnings Fall Y/Y Despite International Strength
KEQU's fiscal Q1 results reflect weaker sales and LPG volumes, partly offset by stronger international profitability and cost control.
Zacks
Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2027
Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2027 Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2027 PR Newswire STATESVILLE, N.C., Sept. 9, 2026 STATESVILLE, N.C., Sept. 9, 2026 /PRNewswire/ --Kewaunee Scientific Corporation (NASDAQ: KEQU) today...
PR Newswire
Kewaunee Scientific Posts Record $282M Revenue, Maps Fiscal 2027 Growth Investments
Kewaunee Scientific Posts Record $282M Revenue, Maps Fiscal 2027 Growth Investments...
Yahoo! Finance: News
Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2027
Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2027 Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2027 PR Newswire STATESVILLE, N.C., Aug. 25, 2026 STATESVILLE, N.C., Aug. 25, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today...
PR Newswire
The Zacks Analyst Blog Highlights Eli Lilly, Costco Wholesale, Morgan Stanley and Kewaunee Scientific
Eli Lilly's expanding GLP-1 portfolio and pipeline remain in focus as demand stays strong ahead of its second-quarter earnings results.
Zacks
Top Research Reports for Eli Lilly, Costco & Morgan Stanley
Eli Lilly's GLP-1 portfolio, pipeline progress and 2026 acquisitions are driving growth despite pricing pressure and rising competition.
Zacks

Advertisement|Remove ads.